US intelligence officials say Chinese pharma companies are risking national security at a time when Washington is considering multiple bills…
Government work report says it wants to mobilize resources to raise China's capacity for innovation to help it to become…
Shares of WuXi Biologics and its affiliate WuXi AppTec plunged again on Wednesday after US lawmakers called for a probe…
Shares of WuXi AppTec and WuXi Biologics sank to multi-year lows on Friday because of deep concern about the proposed…
Move to 'de-risk' supply chains is leading some biotech firms to consider using Indian drug manufacturers to produce active pharmaceutical…
US vaccine maker says it signed agreements with Shanghai officials on developing mRNA vaccines in China. Local news outlet says…
The European Union is set to lay out strategies on 'de-risking' trade with China and other potential military rivals
AstraZeneca is looking at spinning off its business in China - listing it in Hong Kong or Shanghai - in…
The US has added 43 firms – mostly Chinese – to its Entity List, banning them from receiving US exports…
China hawks in Washington blame US investors for transferring capital and valuable know-how to Chinese tech companies that could help…
Tech entrepreneurs say they're looking to base companies abroad, disillusioned with Xi Jinping's policies, and happy to play down their…
Some 24 Chinese firms have changed auditors since 2022, according to an analysis of filings by Nikkei, which said many…